“…Although several (fragment-based) screenings for small molecular antagonists of protein-protein interactions between Ras and its effectors have been proven to be difficult as affinities remain often rather low (Ganguly et al, 1998;Maurer et al, 2012;Rosnizeck et al, 2012;Cox et al, 2014;Schoepel et al, 2016), GTP analogues that bind tightly or even irreversibly to Ras could in principle lead to severe side effects because of unselective crossreactivities towards other GTPases. Nonetheless, a promising study recently reported on selectively targeting a Cys mutant of Ras (Ostrem et al, 2013;Hunter et al, 2014;Min Lim et al, 2014;Wiegandt et al, 2015;Ostrem and Shokat, 2016).…”